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Intestinal peristalsis is a dynamic physiologic pro-
cess influenced by dietary and microbial changes.
It is tightly regulated by complex cellular interac-
tions; however, our understanding of these controls
is incomplete. A distinct population of macro-
phages is distributed in the intestinal muscularis
externa. We demonstrate that, in the steady state,
muscularis macrophages regulate peristaltic activ-
ity of the colon. They change the pattern of smooth
muscle contractions by secreting bone morphoge-
netic protein 2 (BMP2), which activates BMP recep-
tor (BMPR) expressed by enteric neurons. Enteric
neurons, in turn, secrete colony stimulatory factor
1 (CSF1), a growth factor required for macro-
phage development. Finally, stimuli from microbial
commensals regulate BMP2 expression by macro-
phages and CSF1 expression by enteric neu-
rons. Our findings identify a plastic, microbiota-
driven crosstalk between muscularis macrophages
and enteric neurons that controls gastrointestinal
motility.300 Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc.INTRODUCTION
Peristaltic movements of the gut are essential to propel ingested
material through the gastrointestinal (GI) tract. These move-
ments are generated by coordinated contractions and relaxa-
tions of the circular and longitudinal smooth muscles that form
the muscularis externa (Figure 1A). The pattern and frequency
of peristaltic contractions are locally regulated by the enteric
nervous system (ENS) (Furness, 2012) and pacemaker interstitial
cells of Cajal (ICCs) (Huizinga et al., 1995; Rumessen and Van-
derwinden, 2003).
Mononuclear phagocytes, which include dendritic cells (DCs)
and macrophages, form a heterogeneous group of myeloid cells
that are found in most tissues. Their common functions are to
maintain tissue homeostasis through scavenging and participa-
tion in immune responses (Hashimoto et al., 2011b). A network of
MHCII+ macrophages exists in the intestinal muscularis in both
mice and humans (Mikkelsen and Rumessen, 1992; Mikkelsen
et al., 1985). This network extends from the stomach to the distal
colon (Mikkelsen, 2010). Within the muscularis, these macro-
phages mainly accumulate in layers, between the serosa and
the longitudinal muscle, between longitudinal and circular
muscles, and between the outer and inner circular muscles
(Mikkelsen, 2010). In addition to their phagocytic properties
(Mikkelsen et al., 1985), muscularis macrophages (MMs) are
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Figure 1. MHCII+CX3CR1
+ MMs Require
CSF1R Signaling for Their Development
(A and B) Distribution of CX3CR1
+ MMs shown in
cross-section (A) and muscularis sheet (B) of LB
from Cx3cr1-GFP
+/– mice. Scale bar, 100 nm.
(C) Phenotype of MMs in SB muscularis from
Cx3cr1-GFP
+/– mice by fluorescence-activated
cell sorting (FACS) analysis (gated on DAPI– cells).
(D) Flt3 and Csf1r expression in sorted MMs
measured by murine gene expression microarray
and presented as relative units (RU). Data are
presented as mean ± SEM.
(E) FACS plots of whole-bowel suspensions from
WT or Cscf1r–/– mice show the percentage of
CD11cloMHCIIhi MMs (oval gate, solid line) and
CD11chiMHCIIhi LP phagocytes (oval gate, dashed
line). Gated on CD45+CD11clo/hiCD11blo/hi cells as
demonstrated in Figure S1.
(F) Absolute numbers ofMMs in total gut ofWT and
Csf1r–/– mice quantified by FACS (mean ± SEM).
(G) Relative reduction of MMs andCD103+CD11b+
and CD103–CD11b+ LP phagocytes in Csf1r–/–
mice as compared with WT littermates (quantified
by FACS, mean ± SEM).
(H) Percentage of WT CD45.1+ and Csf1r–/–
CD45.2+ cells among CD45+ LP CD103+CD11b+
and LP CD103–CD11b+ phagocytes and MMs
(muscularis) in SB from 10% WT + 90% Csf1r–/–
mixed BM chimeras (mean ± SEM). See also
Figure S1.potent antigen-presenting cells and are sometimes referred to as
DCs (Flores-Langarica et al., 2005).
The functions of MMs are far less defined compared to their
mucosal counterparts. Some studies have implicated MMs in
the pathogenesis of postoperative ileus, a transient inflammatory
condition of theGI tract that results in intestinal paralysis (Mikkel-
sen, 2010). In surgically manipulated areas of the gut, the release
of inflammatory mediators by activated MMs is thought to impair
GI motility by affecting smooth muscle contractility directly, as
well as through the recruitment of additional inflammatory
cells (Boeckxstaens and de Jonge, 2009; Wehner et al., 2007).
WhetherMMs play a role in regulating constitutive GI physiology,
however, has never been determined. Intrigued by the distinctive
distribution of these cells and driven by the idea that macro-
phages are essential regulators of tissue homeostasis (Chow
et al., 2011, 2013; Wynn et al., 2013), we hypothesized that
MMs may provide trophic support to smooth muscle cells and,
through that support, regulate constitutive GI motility.
To test our hypothesis, we developed amodel for the selective
transient depletion of MMs. We then demonstrated that MMsCell 158, 300–regulate intestinal peristalsis at steady
state and identified a specific factor,
BMP2, that is secreted byMMs and regu-
lates GI motility through a direct action,
not on smoothmuscle, but on enteric neu-
rons. Our work revealed that MMs and
enteric neurons communicate with each
other. MMs support enteric neurons by
providing BMP2, whereas neurons pro-mote MM homeostasis through production of the macrophage-
specific growth factor CSF1. Finally, we have found that signals
from the intestinal microbiota are able to influence the crosstalk
between MMs and enteric neurons and alter GI motility.
RESULTS
MM Development Requires CSF1 Receptor Signaling
The intestine is a complex layered structure that includes
the mucosa, submucosa, and muscularis externa (Figure 1A).
The intestinal mucosa is populated by two prevalent subsets
of mononuclear phagocytes (CD103+CD11b+CX3CR1
 DCs
and CD103CD11b+ CX3CR1
+ macrophages), each with a
different developmental pathway and function (Bogunovic
et al., 2009, 2012). Very little is known about the phenotype and
function ofMMs,mainly because thesecells are difficult to isolate
from intestinal tissue. A technique for separating the intestinal
muscularis externa from the overlying mucosa and submucosa
allowed us to perform a detailed analysis of MMs using whole-
mount tissue preparations and single-cell suspensions313, July 17, 2014 ª2014 Elsevier Inc. 301
(Bogunovic et al., 2009). By combining flowcytometry and immu-
nofluorescence analysis, we showed that MMs represent a ho-
mogeneous population of MHCIIhiCD11cloCD103CD11b+ cells
(Bogunovic et al., 2009) that express high levels of CX3CR1 (Fig-
ures 1A–1C). The MM population resembles the
CD103CD11b+CX3CR1
+ macrophages, which are found in the
intestinal lamina propria (LP) (Bogunovic et al., 2009). In a sus-
pension of intestinal cells, MMs can easily be distinguished
from CD11chi LP phagocytes by the lower expression of CD11c
and higher expression of MHCII (Bogunovic et al., 2009; Fig-
ure S1A available online).
FLT3 and CSF1 (also known as macrophage colony stimula-
tory factor [M-CSF]) receptor (CSF1R) are two key growth factor
receptors that control mononuclear phagocyte development
(Hashimoto et al., 2011b). We previously demonstrated that
CD103CD11b+ LP macrophages require CSF1R signaling for
their homeostasis and are reduced in Csf1r/ mice (Bogunovic
et al., 2009). The phenotypic similarity between MMs and
CD103CD11b+ LP macrophages led us to investigate the role
of CSF1R in MM development. We found that MMs express
Csf1r (Figure 1D) and must absolutely be dependent on CSF1R
signaling because Csf1r/ mice lack these cells (Figures 1E–
1G). Moreover, Csf1r/ bone marrow (BM) progenitors fail to
develop into MMs when transplanted into lethally irradiated re-
cipients (Figure 1H).
To study the function of MMs, we developed a model in which
homeostatic properties are used to selectively deplete MMs. We
found that MMs are more dependent on CSF1R signaling than
LP phagocytes (Figures 1G and 1H), which provided us with a
strategy to selectively deplete one population without affecting
the other. Because CSF1R expression in the gut is restricted to
MMs and mucosal macrophages (Figures S1B–S1D; small
bowel (SB) mucosa and submucosa [data not shown]), a single
intraperitoneal (i.p.) injection of a low dose of a blocking anti-
CSF1R monoclonal antibody (Sudo et al., 1995) (aCSF1R mAb)
was able to deplete at least 80% MMs (Figures 2A–2E, S2A,
and S2B) without depleting LP phagocytes (Figures 2C, 2D,
and S2B) or stromal cells (data not shown). MM numbers were
reduced 24 hr after the antibody injection and returned to normal
7 days later (data not shown). No differences in CSF1R levels in
MMs or MM depletion efficiency were observed between the SB
and large bowel (LB) (Figures 2A–2E, S1C, S2A, and S2B). This
depletion was considered to be noninflammatory because there
was no lymphocyte (Figures 2F, S2C, and S2D), neutrophil, or
monocyte (data not shown) recruitment in either the muscularis
or mucosa. Injection of aCSF1R mAb also did not increase
apoptotic cell numbers in the gut (Figure S2E). Taken together,
these findings identified CSF1R as essential for MM develop-
ment and established blocking CSF1R in vivo as a model for
the transient depletion of these cells.
MMs Regulate GI Motility at Steady State
In the isolated intestine, one can elicit the peristaltic reflex by
providing a distending force to the intestinal wall (Frigo and Lec-
chini, 1970). To determine whether conditional depletion of MMs
affects the peristaltic reflex, we developed an ex vivo method
to record peristaltic contractions in response to stepwise
distension of colonic rings (Figure 3A). Repeated applications302 Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc.of increasing stretch resulted in an immediate contraction of
the rings followed by gradual relaxation, creating a ladder-like
pattern of recordings. Augmented stretching generated addi-
tional high-amplitude contractions (further called ‘‘stretch-
induced contractions’’), which gradually increased in amplitude
and frequency (Figure 3B). In MM-depleted colonic rings,
stretch-induced contractions were evoked at shorter durations
of stretch, were more rapid, and had a significantly higher fre-
quency (Figures 3B and 3C); thus the root-mean-square (rms)
of the signal was increased (Figures 3C and 3D). Despite the
evident colonic hyperreactivity ex vivo, colonic transit time,
measured in vivo by bead expulsion assay, was increased after
MM depletion, probably because the muscle contractions
were poorly coordinated and inefficient (Figure 3E). Among other
parameters of GI motility, gastric emptying was accelerated,
whereas transit from the stomach along the SB and total intesti-
nal transit time were not significantly changed (Figures S2F–
S2H). This would occur if accelerated gastric emptying and de-
layed SB and LB motility cancel each other out, thus suggesting
that themotility of the entire GI tract is affected byMMdepletion.
To further confirm the role of MMs in regulating GI motility, we
generated syngeneic BM chimeric animals with Csf1r/ he-
matopoietic progenitors (from fetal liver). Some Csf1r/ BM
chimeric mice clearly developed a delay of colonic transit time
(Figure S2I); however, poor engraftment of Csf1r/ BM and
the consequent low survival rate of these chimeric animals
did not permit us to obtain enough animals for statistical
comparisons.
In summary, the observation that removal of MMs results in
dysmotility indicates that MMs contribute to the physiological
regulation of GI motility.
MMs Regulate Intestinal Peristalsis through the
Production of BMP2
These findings raised the question: by what mechanisms do
MMs affect GI motility? We tested the initial hypothesis that
MMs secrete a soluble factor that alters smooth muscle contrac-
tility. To identify the gene that encodes a putative target protein,
we carried out a murine gene expression microarray on different
purified intestinal phagocyte subsets (Bogunovic et al., 2009,
2012) and did a comparative data analysis to select genes that
are highly expressed by MMs but not by related CD103–CD11b+
LP macrophages. Bone morphogenetic protein 2 (BMP2) was
identified as the only nonimmune gene among the ‘‘top four’’
most highly expressed genes that also encoded a soluble factor
(Cd163, F13a1,Clec4e, and Bmp2; Figures 4A and 4B). No other
BMP family members were expressed by either intestinal phago-
cyte subset (Figures 4C and results not shown). BMPs are a
group of secreted proteins in the transforming growth factor b
(TGF-b) superfamily that are thought to mainly control organ
development (Hogan, 1996). Bmp2–/– mice are embryonically
lethal (Zhang and Bradley, 1996) and Bmp2+/– mice are suscep-
tible to hypoxic pulmonary hypertension characterized by sus-
tained high pressure in pulmonary arteries due to increased
vascular reactivity and structural remodeling (Anderson et al.,
2010). BMP2 is highly expressed in the fetal (but not adult) gut,
and BMP receptor (BMPR) signaling has been implicated in
enteric smooth muscle and neuronal differentiation (Chalazonitis
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Figure 2. Model of MM Depletion
(A and B) FACS plots of separated SBmuscularis (A) and whole SB (B) single-cell suspensions fromWTmice 2 days after i.p. injection of isotype immunoglobulin
G (IgG) or aCSF1RmAb show the percentage of CD11cloMHCIIhi MMs (oval gate, solid line) and CD11chiMHCIIhi LP phagocytes (oval gate, dashed line). (A) Gated
on total viable cells. (B) Gated on CD45+CD11clo/hiCD11blo/hi cells using the gating strategy as in Figure S1.
(C) Absolute numbers of LP CD103+CD11b+ and LP CD103–CD11b+ phagocyte andMMs (muscularis) in the SB of WTmice 2 days after i.p. injection with isotype
IgG or aCSF1R mAb quantified by FACS (mean ± SEM).
(D) Relative reduction of LP phagocyte andMMnumbers quantified by FACS inWTmice treated with aCSF1RmAb (day 2) as compared with isotype IgG-treated
mice (mean ± SEM).
(E and F) Distribution of MHCII+ macrophages (E) and CD3+ T cells (F) in LB muscularis from WT mice 2 days after i.p. injection of isotype IgG or aCSF1R mAb
analyzed by immunofluorescence (IF). Scale bars, 100 nm.
See also Figure S2.et al., 2004, 2008, 2011; Faure et al., 2007b; Fu et al., 2006; Gold-
stein et al., 2005). Using quantitative PCR (qPCR), we confirmed
that Bmp2 is expressed in MMs but is absent in purified muscu-
laris lymphocytes (Figure 4D). In situ BMP2 protein expression
was also restricted to MHCII+ MMs (Figure 4E). To examine
whether BMP2 plays a role in regulating colonic motility, we
compared the patterns of stretch-induced contraction of colonic
rings in mice treated in vivo with the inhibitor of BMPR signaling,
dorsomorphin (Yu et al., 2008), and mice treated only with
vehicle. Treatment with dorsomorphin elicited a pattern of con-
tractile hyperreactivity similar to that seen in colonic rings fromMM-depleted mice (Figures 4F and S3A). To confirm that the
pattern resulted from deficient BMPR signaling, we carried out
a ‘‘rescue’’ experiment in which increasing concentrations of
exogenous BMP2 were added to the colonic rings from MM-
depleted mice. BMP2 was added during recording of stretch-
induced contractions at a previously determined ‘‘optimal’’
2.75 mm stretch distance. BMP2 reduced stretch-induced con-
tractions in a concentration-dependent manner (Figures 4G–4I).
There were no changes in contractility when the same amounts
of BMP2were added to colonic rings in whichMMs had not been
depleted (Figure 4G). Consistent with our in vitro data, BMP2Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc. 303
AB
C D E
Figure 3. Depletion of MMsResults in Intes-
tinal Dysmotility
(A) Illustration of the ex vivo method used to
measure stretch-induced peristaltic contractions
of colonic rings using a myograph.
(B) Five hour recording of stretch-induced con-
tractions of colonic rings during repeated appli-
cations of 0.25-mm-long stretching up to 5.00 mm
total stretch length; 3 mm colonic rings were
obtained fromWTmice 2 days after i.p. injection of
isotype IgG or aCSF1R mAb.
(C) Number of peaks (left) and rms normalized to
baseline in percent (right) during 10min recordings
of colonic contraction at a stretch distance of
2.75 mm.
(D) Rms normalized to baseline (%) during 10 min
recordings of colonic contractions at each
stretching step from 1.5 to 3.5 mm (mean ± SEM).
(E) Colonic transit time measured by bead
expulsion assay in WT mice 1, 3, and 5 days
after i.p. injection of isotype IgG or aCSF1R mAb
(mean ± SEM).
See also Figure S2.injection partially accelerated the colonic transit time (Figure 4J).
Taken together, our data support the idea that MM secretion of
BMP2 regulates colonic contractility.
MMs Activate Enteric Neurons that Express BMPR
We next sought to identify the cells targeted by MM-derived
BMP2. The force with which smooth muscles contract in
response to exogenous stimuli (stretch or KCl) was unaffected
after MM depletion (Figures S3B and S3C). CKit+ ICC and bIII-
Tubulin+ ENS networks do not overlap (Figure S4A). Both ICC
and ENS networks remained intact after MP depletion (Figures
5C and S3D), indicating that acute MM depletion does not
anatomically disrupt ICCs or the ENS. The numbers of epithe-
lial serotonin+ enteroendocrine cells, which activate peristaltic
reflexes in response to luminal signals (Bulbring and Crema,
1959a, 1959b; Heredia et al., 2013), were also unaffected by in-
jection of aCSF1R mAb (Figures S3E and S3F). Additionally, in-
testinal epithelial permeability remained unaffected even after
treatment with maximal doses of aCSF1R mAb (Figures S3G
and S3H). We assessed the anatomical interaction between
MMs and enteric neurons and found that the vast majority of
MMs were positioned along nerve fibers, often forming close
appositions (Figure 5A). BMP2 signals through the oligomeriza-
tion of type I and type II serine kinases (BMPRIa and BMPRII,
respectively), which form BMPR (Kirsch et al., 2000). We found
that BMPRII was selectively expressed by neurons marked by304 Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc.antibodies to bIII-Tubulin (Figure 5B),
but not by ICCs (cKit+; Figure S4B) or
ENS-associated glia (GFAP+; Fig-
ure S4C), suggesting that MMs act on
enteric neurons. Ligand binding to
BMPR activates the canonical signaling
pathway through phosphorylation and
nuclear translocation of SMADs 1, 5,
and 8 (Derynck and Zhang, 2003). Treat-ment of cultured primary enteric neurons, which express BmprIa
and BmprII, but not BmprIb and Bmp2 (Figure S4D), with recom-
binant BMP2 resulted in the rapid accumulation of pSMAD1/5/8
complex in the neuronal nuclei (Figure S4E). Moreover, the
nuclei of the vast majority of BMPRII+ enteric neurons in vivo
were positive for pSMAD1/5/8, demonstrating that activation
through BMPR was constitutively occurring (Figures 5C and
5D). In contrast, MM depletion resulted in the disappearance
of pSMAD1/5/8 from nuclei in most of the enteric neurons in vivo,
consistent with the key contribution of MMs to BMPR signaling
(Figures 5C and 5D). Incubation of the muscularis layer devoid of
MMs with exogenous BMP2 restored the numbers of enteric
neurons with pSMAD1/5/8-immunoreactive nuclei to nearly
normal levels (Figures 5C and 5D). These data imply that MMs
provide continuous signaling to neurons through the secretion
of BMP2, which activates the BMPR that they express.
Enteric Neurons Produce the Macrophage Growth
Factor CSF1
CSF1 and interleukin-34 (IL-34) are two alternative ligands that
activate CSF1R (Lin et al., 2008; Yeung et al., 1987) and each
of these cytokines have been implicated in the development
of different macrophage populations (Greter et al., 2012; Hashi-
moto et al., 2011b;Wang et al., 2012). MMs do not express either
Csf1 (Figure 1A) or Il34 (data not shown), suggesting that
CSF1 and IL-34 must be produced by a different cell
population, possibly stromal cells. CSF1 and Il-34 are alterna-
tively expressed by distinct subtypes of mature neurons in the
postnatal brain (Nandi et al., 2012). We thus asked whether there
is additional crosstalk between enteric neurons and MMs in
which enteric neurons provide CSF1R ligands toMMs.We found
that enteric neurons express Csf1, but not Il34 in culture (Figures
6A and 6B), and are the main source of CSF1 protein in the
muscularis (Figure 6C). As expected, and consistent with an
earlier report (Mikkelsen and Thuneberg, 1999), CSF1-deficient
Csf1op/op mice almost completely lack MMs (Figures 6D–6F).
These results suggest that enteric neurons likely play a key role
in the maintenance of MM homeostasis.
Osteoclast-deficiency-related bone defects in Csf1op/op
mice, including toothlessness (Wiktor-Jedrzejczak et al., 1991)
and their significantly smaller size (Figure S5A), prevented us
from analyzing GI motility in these animals. However, we
observed that, despite the smaller size of both the length and
diameter of the Csf1op/op intestine (length of SB: 80% of WT
[Huynh et al., 2009]; length of LB: 80% of WT), the cecum
of these animals was larger than of WT mice (Figure S5B), sug-
gesting that GI motility is dysregulated in Csf1op/op mice.
Consistent with our data obtained using the transient MM
depletion model, we found that the numbers of pSMAD1/5/8+
enteric neurons were significantly reduced in the colon of
Csf1op/op mice compared with WT littermates (Figures 6G and
S5C). We also observed a significant increase in the total
numbers of enteric neurons together with a less organized
architecture of the ENS in Csf1op/op mice (Figures 6H and 6I),
suggesting the importance of MMs in ENS development. This
observation is similar to previous findings regarding the ENS
of NSE-noggin mice, which overexpress the endogenous
BMP inhibitor noggin under the control of the neuron-specific
enolase (NSE) promoter (Chalazonitis et al., 2004; Chalazonitis
et al., 2008).
Luminal Microbiota Regulate Macrophage-Neuronal
Crosstalk
Luminal microbiota appear to be essential for the normal regu-
lation of intestinal motility, and severe dysmotility has been
described in germ-free rodents (Abrams and Bishop, 1967;
Gustafsson et al., 1970) and in Tlr4–/– and Myd88–/– mice (Ani-
tha et al., 2012). The mechanisms by which commensals regu-
late intestinal motility are poorly understood and may involve
abnormalities of many different cell types. Slowing of GI motility
in germ-free, antibiotic-treated Tlr4–/– and Myd88–/– mice is
accompanied by an alteration in the phenotypic diversity of
enteric neurons with reduced numbers of nitrergic neurons
(Anitha et al., 2012). Whether MMs contribute to these regula-
tory processes is not known. Similarly to published reports
(Abrams and Bishop, 1967; Anitha et al., 2012; Gustafsson
et al., 1970), we found that GI motility is grossly disturbed in
mice treated with broad-spectrum antibiotics (Figures 7A,
S6A, and S6B). Megacolon also occurs in these animals (Fig-
ure S7E), and thus a bead expulsion assay was not valuable
for measuring colonic motility. Upon performing ex vivo ana-
lyses, we found that colonic rings from antibiotic-treated
mice displayed a pattern of contractile hyperreactivity similar
to that seen in colonic rings from MM-depleted or dorsomor-phin-treated mice (Figures 7B and S6C). Strikingly, we found
that antibiotic-treated mice expressed significantly less Bmp2
compared with control mice (Figure 7C), suggesting that micro-
bial commensals influence the interaction between MMs and
enteric neurons. Consistently, the numbers of pSMAD1/5/8+
enteric neurons were significantly reduced in antibiotic-treated
mice compared with littermate controls that received only
water (Figures 7D and S6D). We then questioned whether
commensal signals can also regulate CSF1 production by
enteric neurons. We found that addition of lipopolysaccharide
(LPS) to cultured primary enteric neurons increased their
expression of Csf1 (Figure 7E), whereas culture of primary
enteric neurons in the presence of exogenous BMP2 did not
affect Csf1 expression levels (data not shown). Consistently,
antibiotic treatment in vivo reduced Csf1 expression in the
colonic muscularis (Figure 7F), although the kinetics of Csf1
reduction was slow and reached its minimum after 4 weeks
of treatment (Figure S7A). In line with the reduction of Csf1,
antibiotic treatment also resulted in a decrease of MM numbers
(Figures 7G, S7B, and S7C) with similar kinetics (Figure S7B).
No reduction in the numbers of mucosal macrophages was
observed during the course of antibiotic treatment (data
not shown). Additionally, the numbers of Gr1hi blood mono-
cytes that give rise to both mucosal macrophages (Bogunovic
et al., 2009) and MMs (M.B., unpublished data) were not
affected, thus excluding an effect on myeloid cell development
in the BM (Figure S7D).
Microbiota-associated factors that influence GI motility
include constituents of nutriment breakdown, byproducts of
microbial metabolism, and microbial cellular components
such as LPS (Reigstad and Kashyap, 2013). While cecum
enlargement was an early sign of antibiotic treatment, cecum
size continued to increase over the course of treatment (Fig-
ure S7E), implying that various microbiota-associated factors
contribute to antibiotic-induced dysmotility with different ki-
netics. The kinetics of reduction in Csf1 expression and MM
numbers was delayed as compared with the reduction of bac-
teria in the gut lumen during the antibiotic treatment (Fig-
ure S7F), suggesting that a decrease in serum LPS after pro-
longed antibiotic treatment (Anitha et al., 2012) might be
responsible for those changes. To test this, we supplemented
mice with LPS in drinking water as described previously (Rak-
off-Nahoum et al., 2004) while maintaining them on antibiotics.
Consistent with the in vitro data and our hypothesis, LPS sup-
plementation prevented the reduction of Csf1 expression and
MM numbers (Figures 7F, 7G, and S7C). LPS supplementation
also partially improved GI transit time (Figure 7H) and reduced
cecum size (Figure S7G).
Next, we asked whether the MM-neuronal crosstalk is revers-
ible. Antibiotic-treated mice were reconstituted with microbiota
following fecal transfer (FT) from untreated control mice. Repo-
pulation of luminal bacteria to nearly normal levels (Figure S7H)
was able to restore Csf1 expression (Figure 7F) and MM
numbers (Figure 7G) in the gut, and correct dysmotility (Figure 7I)
and cecum size (Figure S7I).
Taken together, these results demonstrate that the function
of both components of macrophage-neuronal crosstalk can be
reversibly modified by luminal commensals.Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc. 305
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Figure 4. MMs Regulate Intestinal Peristalsis by Secreting BMP2
(A and B) Bmp2 gene expression levels in MMs (muscularis) compared with LP CD103–CD11b+ phagocytes (A) and LP CD103+CD11b+ and LP CD103–CD11b+
phagocytes (B) measured by murine gene expression microarray (mean ± SEM).
(C) Bmp2-7 gene-expression levels in MMs measured by murine gene expression microarray (mean ± SEM).
(D) Bmp2 relative gene-expression levels measured by qPCR in intact SB muscularis (whole tissue) or in SSCloCD45+CD11b– lymphocytes and macrophages
sorted from separated SB muscularis. FI, fold increase as compared with ‘‘whole tissue’’ (mean ± SEM).
(E) IF analysis of LB muscularis from WT mice stained with anti-BMP2 and anti-MHCII mAbs and counterstained with DAPI. Scale bar, 100 nm.
(legend continued on next page)
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DISCUSSION
MMs are thought to regulate GI motility during inflammation
through secretion of inflammatory cytokines and the recruitment
of inflammatory cells, which further accelerate the inflammatory
process (Boeckxstaens and de Jonge, 2009; Mikkelsen, 2010;
Wehner et al., 2007). This mechanism, however, has not been
proven directly to occur. Our data demonstrate that MMs regu-
late GI motility even when the bowel is not inflamed, and MMs
do so through production of the soluble growth factor BMP2.
Whether BMP2 remains a key factor in regulating GI motility dur-
ing inflammation remains to be determined.
Our study suggests that MM-derived BMP2 regulates the
functional activity of neurons, transcending the known role of
this growth factor in neuronal development (Chalazonitis et al.,
2004, 2008). While MMs or MM-specific BMP2 may contribute
to ENS development, as suggested by our data from Csf1op/op
mice, the mechanisms by which BMPs affect homeostasis or
the function(s) of differentiated enteric neurons are not clear.
Studies of BMPR signaling inmotoneurons at the neuromuscular
junction of developing Drosophila larvae suggest that BMPR
signaling regulates themicrotubule stability of axons, fast axonal
transport, and synaptic growth and stability (Aberle et al., 2002;
Eaton and Davis, 2005; Eaton et al., 2002; Nahm et al., 2013;
Wang et al., 2007). More recently, BMPs have been demon-
strated to inhibit constitutive electrical activity in differentiating
neurons of the developing Xenopus spinal cord (Swapna and
Borodinsky, 2012). We postulate that BMPs may exert similar
effects on adult neurons. It is also possible that additional MM-
derived factors can affect the function of enteric neurons. A
recent study revealed the role of the resident macrophages of
the CNS, the microglia, in promoting learning-dependent syn-
apse formation by providing brain-derived neurotrophic factor
(BDNF) to neurons (Parkhurst et al., 2013). Likewise, macro-
phage populations at other sites may participate in regulating
the physiology of organs through mechanisms similar to those
observed in the gut and the brain.
The reduction of BMP2 expression in mice after antibiotic
treatment implies that MMs are sensitive to changes in the
luminal environment, but the mechanism of this sensitivity re-
mains unknown. Interestingly, prolongedHelicobacter hepaticus
infection has been shown to dramatically affect MM activation
and behavior even though Helicobacter never crosses the
epithelial barrier of the gut (Hoffman and Fleming, 2010). It ap-
pears plausible that alterations of MMs occur through a combi-
nation of downstream immune and neuronal surveillance in the
mucosa, including signals provided by Toll-like-receptor-posi-(F) Rms of colonic contraction recordings normalized to baseline (%) at stretch in
with the BMPR inhibitor dorsomorphin or control vehicle (mean ± SEM).
(G) WT mice were injected i.p. with isotype IgG (top) or aCSF1R mAb (bottom) a
contractions of colonic rings from these mice before and after adding 1, 5, or 1
‘‘optimal’’ stretch distance).
(H) Rms of the 10 min recordings described in (G) (bottom: aCSF1R mAb-treated
(I) Rms normalized to baseline (%) of recordings described in (G) (bottom: aCS
(mean ± SEM). Baseline here is the recording at the same stretch distance (2.75
(J) Colonic transit time measured by bead expulsion assay in WT mice before t
aCSF1R mAb; 18 and 3 hr before the last assessment (day 4), the mice received
See also Figure S3.tive enteroendocrine cells (Bogunovic et al., 2007). It is also
possible that MMs recognize commensal components directly
by sensing systemic LPS found in the serum of normal mice (Ani-
tha et al., 2012; Uramatsu et al., 2010).
Chronic disruption of normal peristaltic activity is a charac-
teristic symptom of functional GI disorders such as irritable
bowel syndrome (IBS). In IBS patients, dysmotility-related
symptoms are often accompanied by symptoms associated
with visceral hypersensitivity, an exaggerated perceptual
response to peripheral stimuli that could result from altered
processing of visceral neuronal afferent signals (Faure et al.,
2007a). Histological analysis of full-thickness intestinal biopsies
from IBS patients revealed signs of degenerative or inflamma-
tory neuropathy (Lindberg et al., 2009; To¨rnblom et al., 2002).
Changes in the microbial environment, such as a preceding
bacterial GI infection and SB bacterial overgrowth, have been
proposed to be causes of IBS (Peralta et al., 2009; Pimentel
et al., 2000, 2002, 2003). An improved understanding of the
interplay among enteric neurons, MMs, and luminal signals
may thus provide new therapeutic strategies for the treatment
and/or prevention of IBS.
EXPERIMENTAL PROCEDURES
Mice
All mice were housed in a specific pathogen-free environment at the Mount
Sinai School of Medicine and Penn State College of Medicine and were
used in accordance with protocols approved by the Institutional Animal Care
and Utilization Committees. A list of the mouse strains used is provided in
the Extended Experimental Procedures.
MP depletionwas achieved by single i.p. injection of 37.5 mg/g aCSF1RmAb
(clone AFS98; Sudo et al., 1995) purified from hybridomas as described
previously (Hashimoto et al., 2011a).
Cell Isolation, Flow Cytometry, and Cell Sorting
Single-cell suspensionsof intestinalmuscularisexternaorentirebowelwerepre-
pared, analyzed, and purified as described previously (Bogunovic et al., 2009).
Immunofluorescence
Separated intestinal muscularis externa or cultured enteric neurons were
stained according to a previously described protocol (Bogunovic et al.,
2009) with some modifications and using commercial reagents described in
the Extended Experimental Procedures.
Gene Expression Microarray
A murine gene expression microarray was performed and normalized by
the Immgen Project (http://www.immgen.org) as described previously (Miller
et al., 2012). The gene-expression profile of MMs is posted on www.
immgen.org under ‘‘Small intestine serosal macrophages,’’ abbreviated as
MF.CD11cloSer.SI.tervals of 1.5–3.5 mm; 3 mm colonic rings were obtained fromWTmice treated
nd analyzed 2 days later. Panels show ex vivo recordings of stretch-induced
0 ng of human recombinant BMP2 or control vehicle (performed at 2.75 mm
mice) before and after adding 5 ng of BMP2.
F1R mAb-treated mice) after adding BMP2 (1, 5, or 10 ng) or control vehicle
mm) prior to adding BMP2 or control vehicle.
hey received aCSF1R mAb (day 1) and on days 3 and 4 after they received
1 mg of BMP2 i.p. (mean ± SEM).
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Figure 6. Enteric Neurons Produce CSF1
Required for MM Development
(A) Csf1 gene-expression levels measured
by qPCR in intact muscularis (whole tissue),
macrophages sorted from SB muscularis, and
cultured primary enteric neurons (FI compared
with the ‘‘whole tissue’’). Data are presented as
mean ± SEM.
(B) Il-34 and Csf1 relative gene-expression levels
(FI) measured by qPCR in cultured enteric neurons
as compared with Il-34 (mean ± SEM).
(C) IF analysis of LB muscularis from WT
mice stained with anti-BMPRII and anti-CSF1 Abs.
Scale bar, 100 nm.
(D) FACS plots of whole-bowel single-cell sus-
pensions from WT mice and their Csf1op/op litter-
mates show the percentage of CD11cloMHCIIhi
MMs (oval gate, solid line) and CD11chiMHCIIhi
LP phagocytes (oval gate, dashed line). Gated on
CD45+CD11clo/hiCD11blo/hi cells.
(E) Absolute MM numbers in the bowels of WT
mice and Csf1op/op mice quantified by FACS
(mean ± SEM).
(F) IF analysis of LB (cecum) muscularis from WT
mice and their Csf1op/op littermates stained with
anti-bIII-Tubulin and anti-MHCII Abs. Scale bars,
500 nm.
(G) Quantitative summary of the distribution of
pSMAD1/5/8+BMPRII+ neurons in the LB muscu-
laris from WT and Csf1op/op mice. Each data point
represents the percentage of pSMAD1/5/8+ neu-
rons among total BMPRII+ neurons in each visual
field; each column summarizes the results from
three animals (mean ± SEM).
(H) IF analysis of LB (colon) muscularis from WT
and Csf1op/op littermates stained with anti-BMPRII
Ab. Scale bars, 500 nm.
(I) Quantitative summary of the distribution of
BMPRII+ neurons in the colon of WT and Csf1op/op
mice. Each data point represents the counts of
BMPRII+ neurons in each visual field; each column
summarizes the results from two animals.
See also Figure S5.Real-Time PCR
Real-time PCR was performed as described previously (Bogunovic et al.,
2009) with some modifications as explained in Extended Experimental Proce-
dures. The data were normalized to b-actin. Each data dot on sorted primary
cells was obtained by analyzing RNA from 50,000 cells purified from five to
seven mice. Each data dot from cultured neurons was obtained by analyzing
RNA from an independent primary neuronal culture.Figure 5. MMs Activate BMP2 Receptor on Enteric Neurons
(A) Distribution of CX3CR1
+MMs in colon (left) and ileum (middle and right) muscu
IF. Scale bars, 500 nm (left), 100 nm (middle), and 10 nm (right).
(B) IF analysis of LB muscularis fromWTmice stained with anti-BMPRII and anti-b
(C) IF analysis of LB muscularis from WT mice 2 days after i.p. injection of isotype
and anti-BMPRII Abs and counterstained with DAPI. The bottom panel shows pS
that was incubated with BMP2 as described in (D). Scale bars, 100 nm.
(D) Quantitative summary of the distribution of pSMAD1/5/8+BMPRII+ neurons in t
mAb. In all cases, the muscularis was incubated for 30 min at 37C in complete m
point represents the percentage of pSMAD1/5/8+ neurons among the total BMPR
animals (mean ± SEM).
See also Figures S3 and S4.Colonic Peristalsis Ex Vivo
The method used to measure colonic peristalsis ex vivo is described in the
ExtendedExperimentalProcedures. ToblockBMPRsignaling,13mg/g (Helbing
et al., 2011) of dorsomorphin (Sigma) in DMSOwas injected i.p. 18 and 2 hr prior
toanalysis. InBMP2 ‘‘rescue’’ experiments thecolonic ringsweredistendeduntil
2.75 mm. A baseline recording of 40 min was taken, after which recombinant
human BMP2 (R&D Systems) dissolved in 4 mM HCl was cumulatively addedlaris fromCx3cr1-GFP
+/– mice stained with anti-bIII-Tubulin Ab and analyzed by
III-Tubulin antibodies (Abs) and counterstained with DAPI. Scale bars, 500 nm.
IgG (top) or aCSF1R mAb (middle and bottom), stained with anti-pSMAD1/5/8
MAD1/5/8 distribution in the muscularis from an aCSF1R mAb-injected mouse
hemuscularis fromWTmice 2 days after i.p. injection of isotype IgG or aCSF1R
edium in the presence or absence of BMP2 (10 ng/ml) as indicated. Each data
II+ neurons in each visual field; each column summarizes the results from three
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Figure 7. Luminal Microbiota Regulates
Intestinal Motility and MM-Neuronal Cross-
talk
(A–D) WT mice received antibiotics with drinking
water for 4 weeks and control age-matched mice
received only water.
(A) Total GI transit time, which represents the time
required to expel feces containing carmine red
dye, was measured in antibiotic-treated and con-
trol mice (mean ± SEM).
(B) Rms of colonic contraction recordings
normalized to baseline (%) at stretch intervals of
1.5–3.5 mm (mean ± SEM); 3 mm colonic rings
were obtained from antibiotic-treated and control
mice.
(C) Bmp2 relative gene-expression levels
measured by qPCR in MMs sorted from SB mus-
cularis of antibiotic-treated and control mice. FI,
fold increase as compared with Bmp2 levels in the
intact muscularis (mean ± SEM). Each data point
represents qPCR results obtained from analyzing
50,000 cells after a single sort from five mice. Cell
sorting from each group was performed in pairs on
the same day and under identical conditions.
(D) Quantitative summary of the distribution of
pSMAD1/5/8+BMPRII+ neurons in the muscularis
from antibiotic-treated and control mice. Each
data point represents the percentage of pSMAD1/
5/8+ neurons among total BMPRII+ neurons in
each visual field; each column summarizes the
results from three animals (mean ± SEM).
(E) Csf1 relative gene-expression levels in cultured
primary enteric neurons measured by qPCR.
Differentiated neurons were cultured with or
without 10 ng/ml of LPS for 18 hr prior to analyses.
FI, fold increase as compared with Csf1 levels in the intact muscularis (mean ± SEM). Each data point represents qPCR results obtained from an independent
neuronal culture.
(F) Csf1 relative gene-expression levels quantified by qPCR in LB muscularis from WT mice treated with antibiotics for 4 weeks (left), WT mice treated with
antibiotics and 50 mg/ml LPS in drinking water for 4 weeks (middle), and WT mice 3 weeks after they received fecal transfer (FT) following a 4-week course of
antibiotics (right). The data are compared with data for age-matched control mice that received only water. FI, fold increase as comparedwith averageCsf1 levels
in the control group that received water (mean ± SEM).
(G) Absolute numbers of MMs quantified by FACS in LB from WT mice that received antibiotics (left), antibiotics with LPS (middle), and FT following antibiotic
treatment (right) as in (F). The data are compared with data for age-matched control mice that received only water (mean ± SEM).
(H) Total GI transit time inWTmice that received antibiotics and 50 mg/ml LPSwith drinkingwater for 4 weeks and age-matchedmice that received only antibiotics
for 4 weeks (mean ± SEM).
(I) Total GI transit time in WT mice 3 weeks after they received FT following a 4-week course of antibiotics and control mice that received water (mean ± SEM).
See also Figures S6 and S7.to the bath (1, 5, and 10 ng per 8 ml organ bath) followed by 10 min of recording
between doses. The dose response to KCl was determined by distending the
colonic rings until a baseline force of 0.5 mN was achieved. The rings were
allowed to equilibrate for 2.5 hr, with hourly solution changes. Increasing con-
centrations of KCl (0, 10, 40, 80, 100, and 200 mM) were added to the bath
and solution was changed after 5 min. Ratios were calculated as baseline force
prior to KCl addition over maximal contractile force after KCl addition.
GI Motility
Colonic transit time was detected by bead expulsion assay (Li et al., 2006).
Gastric emptying, SB transit, and total intestinal transit time were measured
as described previously (Li et al., 2011). Control and experimental groups
were age and sex matched. For in vivo ‘‘rescue’’ experiments, human recom-
binant BMP2 (Peprotech) was injected i.p. (50 ng/g of body weight) 18 and 3 hr
prior to measuring colonic transit time.
Epithelial Permeability
Epithelial permeability studies were performed as described previously (Dahan
et al., 2011).310 Cell 158, 300–313, July 17, 2014 ª2014 Elsevier Inc.In Vitro Culture of Enteric Neurons
In vitro culture of enteric neuronswas prepared from embryonic intestines from
embryonic day 17 (E17) as described in Extended Experimental Procedures.
Antibiotic Treatment
For antibiotic treatment, a variation of a published protocol (Rakoff-Nahoum
et al., 2004) was used. Six to 7-week-old female mice were given drinking
water containing 1 g/l of ampicillin (Teknova), 1 g/l of streptomycin (GIBCO),
1 g/l of metronidazole (Sigma), and 1 g/l of vancomycin (Sigma) for 1–4 weeks.
For LPS supplementation, mice were given 50 mg/ml of LPS from E. coli
O111:B4 (Sigma) in drinking water (Rakoff-Nahoum et al., 2004) together
with antibiotics for 4 weeks.
Fecal Transfer
Recipient mice were placed on antibiotic-free water 24 hr prior to FT. Intestinal
contents from donor mice, prepared as described in Extended Experimental
Procedures, were given to recipient mice by oral gavage. Donor mice were
age matched, obtained from the same vendor, and maintained in the same fa-
cility as the recipients of FT.
Bacterial 16S rDNA qPCR
Bacterial 16S rDNA qPCR to quantify fecal bacterial DNA was performed as
described in the Extended Experimental Procedures.
Statistical Analysis
Data are presented as mean ± SEM. The statistical significance of differences
between group means was determined with the two-tailed unpaired or paired
Student’s t test and one-way ANOVA. Values of p < 0.05 (*), p < 0.005 (**), and
p < 0.0005 (***) indicate statistical significance.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.04.050.
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